CLINICAL PREDICTORS OF CARDIOVASCULAR OUTCOMES IN PATIENTS ON CELECOXIB, IBUPROFEN, AND NAPROXEN

Haris Riaz,Grant Reed,Qiuqing Wang,Lisa Wisniewski,Kathy Wolski,A. Lincoff,Steven Nissen

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2019）

引用 1|浏览23

暂无评分

摘要

The PRECISION trial established the cardiovascular (CV) safety of celecoxib was non-inferior to ibuprofen and naproxen in patients with non-steroidal anti-inflammatory drug (NSAID) dependent arthritis. Herein, we describe the clinical predictors of CV events in PRECISION.23,953 patients dependent

查看译文

关键词

cardiovascular outcomes,ibuprofen,celecoxib,clinical predictors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要